Screening by anti-endomysium antibodies for celiac disease in Tunisian children with type 1 diabetes mellitus (Q39211197)

10 September 2017

Screening by anti-endomysium antibodies for celiac disease in Tunisian children with type 1 diabetes mellitus (English)

1 reference

10 September 2017

0 references

0 references

0 references

1 reference

Amani Mankaï

1

1 reference

10 September 2017

Hechmi Ben Hamouda

2

1 reference

10 September 2017

Fethi Amri

3

1 reference

10 September 2017

Leila Ghedira-Besbes

4

1 reference

10 September 2017

Abdelaziz Harbi

5

1 reference

10 September 2017

Mohamed Tahar Sfar

6

1 reference

10 September 2017

Ahmed Sahloul Essoussi

7

1 reference

10 September 2017

Moncef Jeddi

8

1 reference

10 September 2017

Ibtissem Ghedira

9

1 reference

10 September 2017

1 May 2007

1 reference

Gastroenterologie Clinique et Biologique

10 September 2017

1 reference

10 September 2017

31

1 reference

10 September 2017

5

1 reference

10 September 2017

462-466

1 reference

Screening for celiac disease in Tunisian patients with Graves' disease using anti-endomysium and anti-tissue transglutaminase antibodies

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Screening for coeliac disease in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Celiac disease in Tunisia: serological screening in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Why is coeliac disease endemic in the people of the Sahara?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Prevalence of Celiac disease among children in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Screening by Anti-Endomysium Antibody for Celiac Disease in Diabetic Children and Adolescents in Austria

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Morphology of the mucosal lesion in gluten sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Endomysium antibodies in coeliac disease: an improved method

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

IgA endomysium antibodies on human umbilical cord: an excellent diagnostic tool for celiac disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

[Anti-endomysium, anti-reticulin and anti-gliadin antibodies, value in the diagnosis of celiac disease in the child]

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Patients with serum IgA endomysial antibodies and intact duodenal villi: clinical characteristics and management options

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Diagnosis of coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: A multicenter survey

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Coeliac disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Gynecologic and obstetric findings related to nutritional status and adherence to a gluten-free diet in Brazilian patients with celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

Case-finding in coeliac disease should be intensified

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2807%2989413-9

7 January 2021

10.1016/S0399-8320(07)89413-9

Identifiers

DOI

1 reference

10 September 2017

1 reference